• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加利福尼亚州旧金山三个不同高危人群中 HCV 基因型分布的时间变化。

Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California.

机构信息

Núcleo de Estudos e Pesquisas em Atenção ao Uso de Drogas (NEPAD)-Universidade do Estado do Rio de Janeiro (State University of Rio de Janeiro), 20940-200 Rio de Janeiro, RJ, Brasil.

出版信息

BMC Infect Dis. 2011 Aug 2;11:208. doi: 10.1186/1471-2334-11-208.

DOI:10.1186/1471-2334-11-208
PMID:21810243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3199778/
Abstract

BACKGROUND

Hepatitis C virus (HCV) genotype (GT) has become an important measure in the diagnosis and monitoring of HCV infection treatment. In the United States (U.S.) HCV GT 1 is reported as the most common infecting GT among chronically infected patients. In Europe, however, recent studies have suggested that the epidemiology of HCV GTs is changing.

METHODS

We assessed HCV GT distribution in 460 patients from three HCV-infected high risk populations in San Francisco, and examined patterns by birth cohort to assess temporal trends. Multiple logistic regression was used to assess factors independently associated with GT 1 infection compared to other GTs (2, 3, and 4).

RESULTS

Overall, GT 1 was predominant (72.4%), however younger injection drug users (IDU) had a lower proportion of GT 1 infections (54.7%) compared to older IDU and HIV-infected patients (80.5% and 76.6%, respectively). Analysis by birth cohort showed increasing proportions of non-GT 1 infections associated with year of birth: birth before 1970 was independently associated with higher adjusted odds of GT 1: AOR 2.03 (95% CI: 1.23, 3.34). African-Americans as compared to whites also had higher adjusted odds of GT 1 infection (AOR: 3.37; 95% CI: 1.89, 5.99).

CONCLUSIONS

Although, HCV GT 1 remains the most prevalent GT, especially among older groups, changes in GT distribution could have significant implications for how HCV might be controlled on a population level and treated on an individual level.

摘要

背景

丙型肝炎病毒(HCV)基因型(GT)已成为 HCV 感染诊断和治疗监测的重要指标。在美国(U.S.),报告称慢性感染患者中最常见的感染 GT 是 HCV GT1。然而,在欧洲,最近的研究表明 HCV GT 的流行病学正在发生变化。

方法

我们评估了来自旧金山三个 HCV 感染高危人群的 460 名患者的 HCV GT 分布,并通过出生队列检查模式,以评估时间趋势。多因素逻辑回归用于评估与其他 GT(2、3 和 4)相比,与 GT1 感染相关的独立因素。

结果

总体而言,GT1 占主导地位(72.4%),但年轻的静脉注射吸毒者(IDU)的 GT1 感染比例较低(54.7%),与年长的 IDU 和 HIV 感染者(80.5%和 76.6%)相比。按出生队列分析显示,与出生年份相关的非 GT1 感染比例增加:出生于 1970 年之前与 GT1 的调整后比值比(AOR)独立相关,AOR 为 2.03(95%CI:1.23,3.34)。与白人相比,非裔美国人感染 GT1 的调整后比值比(AOR)也更高(AOR:3.37;95%CI:1.89,5.99)。

结论

尽管 HCV GT1 仍然是最常见的 GT,尤其是在年龄较大的人群中,但 GT 分布的变化可能对 HCV 在人群水平上的控制和个体水平上的治疗产生重大影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ba/3199778/e17205f8d272/1471-2334-11-208-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ba/3199778/e17205f8d272/1471-2334-11-208-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9ba/3199778/e17205f8d272/1471-2334-11-208-1.jpg

相似文献

1
Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California.加利福尼亚州旧金山三个不同高危人群中 HCV 基因型分布的时间变化。
BMC Infect Dis. 2011 Aug 2;11:208. doi: 10.1186/1471-2334-11-208.
2
New findings in HCV genotype distribution in selected West European, Russian and Israeli regions.在选定的西欧、俄罗斯和以色列地区丙型肝炎基因型分布的新发现。
J Clin Virol. 2016 Aug;81:82-9. doi: 10.1016/j.jcv.2016.05.010. Epub 2016 May 24.
3
Evolution of the prevalence of hepatitis C virus infection and hepatitis C virus genotype distribution in human immunodeficiency virus-infected patients in Italy between 1997 and 2015.1997 年至 2015 年间意大利人类免疫缺陷病毒感染患者丙型肝炎病毒感染和丙型肝炎病毒基因型分布的流行演变。
Clin Microbiol Infect. 2018 Apr;24(4):422-427. doi: 10.1016/j.cmi.2017.07.021. Epub 2017 Jul 29.
4
Increase of drug use and genotype 3 in HCV-infected patients from Central West and Northeast Mexico.墨西哥中西部和东北部丙型肝炎病毒感染患者药物使用情况增加及3型基因型感染情况
Ann Hepatol. 2015 Sep-Oct;14(5):642-51.
5
Analysis of Transmission Routes of Hepatitis C Virus Based on Virus Genotyping in 341 Cases with Different Suspected Initial Infection Time Points in Hunan Province, China.基于湖南省 341 例不同疑似初次感染时间点病例的病毒基因分型分析丙型肝炎病毒的传播途径。
Med Sci Monit. 2018 Jul 28;24:5232-5241. doi: 10.12659/MSM.907424.
6
[Investigation of hepatitis C virus genotype distribution in patients with chronic hepatitis C infections in Antalya Training and Research Hospital, Turkey].[土耳其安塔利亚培训与研究医院慢性丙型肝炎感染患者丙型肝炎病毒基因型分布调查]
Mikrobiyol Bul. 2014 Jul;48(3):484-90. doi: 10.5578/mb.7288.
7
HCV screening in a cohort of HIV infected and uninfected homeless and marginally housed women in San Francisco, California.在加利福尼亚州旧金山的一群感染和未感染艾滋病毒的无家可归及住房条件差的妇女中进行丙型肝炎病毒筛查。
BMC Public Health. 2017 Feb 7;17(1):171. doi: 10.1186/s12889-017-4102-5.
8
A decade of hepatitis C at the University of Cape Town/Groote Schuur Hospital Liver Clinic, South Africa, in the pre-direct-acting antivirals era.南非开普敦大学/格罗特舒尔医院肝脏诊所在直接作用抗病毒药物时代前的十年丙型肝炎治疗情况。
S Afr Med J. 2020 Jan 29;110(2):106-111. doi: 10.7196/SAMJ.2020.v110i2.14208.
9
Race, Age, and Geography Impact Hepatitis C Genotype Distribution in the United States.种族、年龄和地理位置影响美国丙型肝炎基因型分布。
J Clin Gastroenterol. 2019 Jan;53(1):40-50. doi: 10.1097/MCG.0000000000000872.
10
Epidemiological survey of hepatitis C virus infection in a cohort of patients from a ser.T in naples, Italy.意大利那不勒斯某队列丙型肝炎病毒感染的流行病学调查。
J Addict Med. 2011 Mar;5(1):43-9. doi: 10.1097/ADM.0b013e3181d131e0.

引用本文的文献

1
Global elimination of hepatitis C virus infection: Progresses and the remaining challenges.全球消除丙型肝炎病毒感染:进展与尚存挑战
World J Hepatol. 2017 Nov 28;9(33):1239-1252. doi: 10.4254/wjh.v9.i33.1239.
2
Cost-Effectiveness of One-Time Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care Settings.一次性丙型肝炎筛查策略在初级保健环境中青少年和年轻成人中的成本效益。
Clin Infect Dis. 2018 Jan 18;66(3):376-384. doi: 10.1093/cid/cix798.
3
Race, Age, and Geography Impact Hepatitis C Genotype Distribution in the United States.

本文引用的文献

1
Hepatitis C virus genotypes in clinical specimens tested at a national reference testing laboratory in the United States.美国国家参考检测实验室检测的临床标本中的丙型肝炎病毒基因型。
J Clin Microbiol. 2011 Aug;49(8):3040-3. doi: 10.1128/JCM.00457-11. Epub 2011 May 25.
2
A case-control study of factors associated with resolution of hepatitis C viremia in former blood donors (CME).一项关于与既往献血者丙型肝炎病毒血症清除相关因素的病例对照研究(继续教育)。
Transfusion. 2010 Jul;50(7):1513-23. doi: 10.1111/j.1537-2995.2010.02634.x. Epub 2010 Mar 25.
3
Challenges for rapid molecular HIV diagnostics.
种族、年龄和地理位置影响美国丙型肝炎基因型分布。
J Clin Gastroenterol. 2019 Jan;53(1):40-50. doi: 10.1097/MCG.0000000000000872.
4
The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection.基于索磷布韦的治疗方案用于丙型肝炎病毒2型或3型感染的成本效益
Ann Intern Med. 2015 May 5;162(9):619-29. doi: 10.7326/M14-1313.
5
Mixed HCV infection and reinfection in people who inject drugs--impact on therapy.混合 HCV 感染和再感染在注射毒品者中的情况 - 对治疗的影响。
Nat Rev Gastroenterol Hepatol. 2015 Apr;12(4):218-30. doi: 10.1038/nrgastro.2015.36. Epub 2015 Mar 17.
6
Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs.在药物滥用治疗项目中进行丙型肝炎病毒(HCV)快速检测以及同时进行HCV和HIV快速检测的成本效益分析。
Addiction. 2015 Jan;110(1):129-43. doi: 10.1111/add.12754.
7
Virologic characterization of genotype 4 hepatitis C virus variants in patients treated with telaprevir.替拉瑞韦治疗患者中基因型 4 丙型肝炎病毒变异株的病毒学特征
Virol J. 2014 May 16;11:93. doi: 10.1186/1743-422X-11-93.
8
The hepatitis C cascade of care: identifying priorities to improve clinical outcomes.丙型肝炎防治链:确定改善临床结局的优先事项。
PLoS One. 2014 May 19;9(5):e97317. doi: 10.1371/journal.pone.0097317. eCollection 2014.
9
HCV genotypes, characterization of mutations conferring drug resistance to protease inhibitors, and risk factors among blood donors in São Paulo, Brazil.巴西圣保罗地区献血者中的 HCV 基因型、对蛋白酶抑制剂耐药性的突变特征以及相关危险因素。
PLoS One. 2014 Jan 21;9(1):e86413. doi: 10.1371/journal.pone.0086413. eCollection 2014.
10
Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors.美国献血者中新获得和流行的 HIV、乙型肝炎病毒和丙型肝炎病毒感染的遗传多样性。
J Infect Dis. 2012 Mar 15;205(6):875-85. doi: 10.1093/infdis/jir862. Epub 2012 Jan 31.
快速分子 HIV 诊断面临的挑战。
J Infect Dis. 2010 Apr 15;201 Suppl 1(Suppl 1):S1-6. doi: 10.1086/650394.
4
Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial/ethnic composition and need.纽约市卫生区可购买非处方注射器的药店空间可达性的时空趋势:与当地种族/民族构成和需求的关系。
J Urban Health. 2009 Nov;86(6):929-45. doi: 10.1007/s11524-009-9399-7.
5
Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection.年轻成年注射吸毒者的急性丙型肝炎病毒感染:一项关于新发感染、康复及再感染的前瞻性研究。
J Infect Dis. 2009 Oct 15;200(8):1216-26. doi: 10.1086/605947.
6
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.白细胞介素28B的基因变异与丙型肝炎病毒的自发清除
Nature. 2009 Oct 8;461(7265):798-801. doi: 10.1038/nature08463.
7
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.白细胞介素28B的基因变异可预测丙型肝炎治疗诱导的病毒清除情况。
Nature. 2009 Sep 17;461(7262):399-401. doi: 10.1038/nature08309. Epub 2009 Aug 16.
8
Hepatitis C vaccine: supply and demand.丙型肝炎疫苗:供应与需求
Lancet Infect Dis. 2008 Jun;8(6):379-86. doi: 10.1016/S1473-3099(08)70126-9.
9
Changing HCV genotypes distribution in Poland--relation to source and time of infection.波兰丙型肝炎病毒基因型分布的变化——与感染源及感染时间的关系
J Clin Virol. 2008 Jun;42(2):156-9. doi: 10.1016/j.jcv.2008.02.001. Epub 2008 Mar 19.
10
Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.在未接受治疗且血浆HIV RNA水平检测不到的HIV血清阳性个体中,T细胞活化与CD4+ T细胞计数之间的关系。
J Infect Dis. 2008 Jan 1;197(1):126-33. doi: 10.1086/524143.